Cargando…

Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?

Data on therapeutic drug monitoring of novel, broad-spectrum, and promising antifungal agent Isavuconazole sheds light on factors associated with subtherapeutic drug levels, however, a few other parameters, which characterize the critically ill patients, if included in the analysis, would have impro...

Descripción completa

Detalles Bibliográficos
Autor principal:	Salhotra, Ripenmeet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291658/ https://www.ncbi.nlm.nih.gov/pubmed/37378375 http://dx.doi.org/10.5005/jp-journals-10071-24450

Ejemplares similares

Author Reply: Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India
por: Prayag, Parikshit Shirish
Publicado: (2023)

Penetration of Isavuconazole in Ascites Fluid of Critically Ill Patients
por: Lahmer, Tobias, et al.
Publicado: (2021)

Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
por: Bolcato, Léa, et al.
Publicado: (2022)

Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection
por: Novy, Emmanuel, et al.
Publicado: (2020)

New Antibiotic Prescription Pattern in Critically Ill Patients (“Ant-critic”): Prospective Observational Study from an Indian Intensive Care Unit
por: Ghosh, Supradip, et al.
Publicado: (2022)

Implementation of a Revised Montpellier Bundle on the Outcome of Intubation in Critically Ill Patients: A Quality Improvement Project
por: Ghosh, Supradip, et al.
Publicado: (2022)

Is it sufficient to evaluate COVID‐19 infected critically ill patients only in terms of VTE risk factors? What about disease severity?
por: Yildirim, Fatma, et al.
Publicado: (2022)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
por: Honore, Patrick M., et al.
Publicado: (2018)

What about incorporating selenium in the therapeutic regimen of SARS-CoV-2?
por: Benarba, Bachir, et al.
Publicado: (2020)

Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole
por: Risum, Malene, et al.
Publicado: (2021)

Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies
por: Jansen, Anouk M. E., et al.
Publicado: (2023)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Our insight about Mukhtar et al.’s outcome of non-invasive ventilation in COVID-19 critically ill patients
por: Karim, Habib Md Reazaul, et al.
Publicado: (2021)

What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?
por: Cauchie, Philippe, et al.
Publicado: (2021)

Impact of Prophylactic Noninvasive Ventilation on Extubation Outcome: A 4-year Prospective Observational Study from a Multidisciplinary ICU
por: Ghosh, Supradip, et al.
Publicado: (2021)

Is gastric residual volume monitoring in critically ill patients receiving mechanical ventilation an evidence-based practice?
por: Heydari, Abbas, et al.
Publicado: (2014)

What was said about COVID-19 and what we heard and what we saw!
por: Rostami, Mojtaba, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
por: Gorham, Julie, et al.
Publicado: (2023)

Liberal Versus Conservative Fluid Therapy in COVID-19 Patients: What is the Best Strategy for the Treatment of Critically ill Patients?
por: Bohórquez-Rivero, José de Jesús, et al.
Publicado: (2022)

What about rheumatic diseases and COVID-19?
por: Aouissi, H.A., et al.
Publicado: (2021)

What is the optimal fluid status in critically ill patients?
por: Chou, Yu-Hsiang
Publicado: (2012)

Vitamin D Deficiency in Critically Ill
por: Angurana, Suresh Kumar, et al.
Publicado: (2017)

Critical Illness Polyneuromyopathy and the Diagnostic Dilemma
por: Sulakshana, Sulakshana, et al.
Publicado: (2020)

Therapeutic drug monitoring of lithium therapy at a psychiatric hospital in Namibia
por: Singu, Bonifasius Siyuka, et al.
Publicado: (2023)

Responses to the Criticisms about “The Accreditation of Hospitals in Iran”
por: BAHADORI, Mohammadkarim, et al.
Publicado: (2016)

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response
por: Kovanda, Laura L., et al.
Publicado: (2017)

Therapeutic efficacy of isavuconazole in experimental Aspergillus fumigatus endophthalmitis
por: Guest, John, et al.
Publicado: (2017)

Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets
por: Drewett, George P., et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India
por: Prayag, Parikshit Shirish, et al.
Publicado: (2023)

Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
por: Stessel, Björn, et al.
Publicado: (2021)

What is actual condition of working parents about child nurturing and what they have to do?
por: Mukhida, Sahjid S., et al.
Publicado: (2023)

What about Memory, Consciousness, Recall, and Awareness in Anesthesia?
por: Cascella, Marco
Publicado: (2014)

Erythema nodosum: what should we consider about it?
por: Babamahmoudi, Farhang, et al.
Publicado: (2016)

What about social determinants of health against xenophobia?
por: Adja, K.Y.C., et al.
Publicado: (2020)

Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
por: Stockmann, Chris, et al.
Publicado: (2016)

Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
por: Truta, Brindusa
Publicado: (2022)

Acanthamoeba spp. in Urine of Critically Ill Patients
por: Santos, Leonilda C., et al.
Publicado: (2009)

Pediatric critical illness associated cerebral microhemorrhages
por: Abdul Rashid, Anna Misyail, et al.
Publicado: (2019)

Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles?
por: Cojutti, Pier Giorgio, et al.
Publicado: (2021)

Bifid Epiglottis: What Perioperative Physician Should Know about It?
por: Yadav, Rupesh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t0soogeui75ob27kqe14j941al